Our results characterize PTEN protein immunohistochemical expression in canine gliomas for the first time and demonstrate a variable reduction in its expression in a subset of high-grade canine gliomas, being more frequent in those from an astrocytic origin. The gene discussed is PTEN; the disease is central nervous system cancer.